Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/16/25 19:07 | 5/16/25 | TNYA | Health | BioPrd | Biological Products, (No Diag | Higa Tomohiro | CA | O | SVP,Fina | 2 | S | -2 | 0.5039 | 0 | -4 | 100 | D | |||||||||||||||
5/16/25 19:07 | 5/16/25 | TNYA | Health | BioPrd | Biological Products, (No Diag | Tingley Whittemore | CA | O | Chief Me | 4 | S | -65 | 2.67 | 0 | -24 | 175 | D | |||||||||||||||
5/16/25 19:07 | 5/16/25 | TNYA | Health | BioPrd | Biological Products, (No Diag | Ali Faraz | CA | DO | CEO | 4 | S | -72 | 2.48 | 0 | -29 | 321 | D | |||||||||||||||
11/18/24 20:48 | 11/18/24 | TNYA | Health | BioPrd | Biological Products, (No Diag | Saito Chihiro | CA | O | SVP,Acco | 2 | S | -12 | 2.52 | 0 | -5 | 63 | D | |||||||||||||||
3/6/24 18:45 | 3/5/24 | TNYA | Health | BioPrd | Biological Products, (No Diag | Hoey Timothy | CA | O | Chief Sc | 3 | S | -86 | 5.88 | 0 | -15 | 245 | D | |||||||||||||||
2/16/24 20:32 | 2/16/24 | TNYA | Health | BioPrd | Biological Products, (No Diag | Patterson Leone D | CA | O | Chief Fi | 1 | S | -30 | 5.86 | 0 | -5 | 61 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |